Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line.
Morale MG
,
Tamura RE
,
Cintra R
,
Araújo NM
,
Villa LL
.
???displayArticle.abstract???
Human Papillomavirus is responsible for a wide range of mucosal lesions and tumors. The immune system participate in tumorigenesis in different ways. For example, signaling pathways triggered by Toll-like receptors (TLR) play a role in chemotherapy resistance in several tumor types and are candidates for contributing to the development of HPV-induced tumors. Here, we studied the receptor TLR4 and the adaptor molecule SARM1 in HeLa cells, an HPV-positive cervical cancer cell line. Knocking out of these genes individually proved to be important for maintaining cell viability and proliferation. TLR4 knock out cells were more sensitive to cisplatin treatment, which was illustrated by an increased frequency of apoptotic cells. Furthermore, TLR4 and SARM1 modulated ROS production, which was induced by cell death in response to cisplatin. In conclusion, TLR4 and SARM1 are important for therapy resistance and cervical cancer cell viability and may be relevant clinical targets.
Aggarwal,
Inflammation and cancer: how hot is the link?
2006, Pubmed
Aggarwal,
Inflammation and cancer: how hot is the link?
2006,
Pubmed
Artaza-Irigaray,
E6/E7 and E6* From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes.
2019,
Pubmed
Arvanitis,
Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study.
2008,
Pubmed
Belinda,
SARM: a novel Toll-like receptor adaptor, is functionally conserved from arthropod to human.
2008,
Pubmed
Bhatelia,
TLRs: linking inflammation and breast cancer.
2014,
Pubmed
Boccardo,
Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
2010,
Pubmed
Bosch,
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.
2003,
Pubmed
Carpenter,
How important are Toll-like receptors for antimicrobial responses?
2007,
Pubmed
Carty,
The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
2006,
Pubmed
Daud,
Association between toll-like receptor expression and human papillomavirus type 16 persistence.
2011,
Pubmed
Donnellan,
Cyclin D1 and human neoplasia.
1998,
Pubmed
Doorbar,
The biology and life-cycle of human papillomaviruses.
2012,
Pubmed
Fu,
Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
2020,
Pubmed
Garcia-Chacon,
Immunobiology of HPV Infection.
2009,
Pubmed
Gorski,
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer.
2020,
Pubmed
Grote,
Toll-like receptors in angiogenesis.
2011,
Pubmed
Guleria,
Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
2019,
Pubmed
Han,
Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions.
2020,
Pubmed
Hasan,
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
2007,
Pubmed
Hasimu,
Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.
2011,
Pubmed
Hunt,
Cyclin E as a prognostic and predictive marker in breast cancer.
2005,
Pubmed
Ioannou,
Toll-like receptors, tissue injury, and tumourigenesis.
2010,
Pubmed
Jiang,
The effect of TLR4 on the growth and local inflammatory microenvironment of HPV-related cervical cancer in vivo.
2020,
Pubmed
Kashani,
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid).
2020,
Pubmed
Kelly,
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.
2006,
Pubmed
Lin,
Sarm1, a neuronal inflammatory regulator, controls social interaction, associative memory and cognitive flexibility in mice.
2014,
Pubmed
Livak,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
2001,
Pubmed
Luo,
Signalling, sorting and scaffolding adaptors for Toll-like receptors.
2019,
Pubmed
Morale,
HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis.
2018,
Pubmed
Morales-Garcia,
The high-risk HPV E6 proteins modify the activity of the eIF4E protein via the MEK/ERK and AKT/PKB pathways.
2020,
Pubmed
Morgan,
Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.
2019,
Pubmed
Muccioli,
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies.
2014,
Pubmed
Murata,
SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria.
2013,
Pubmed
Oliveira,
Human papillomavirus (HPV) 16 E6 oncoprotein targets the Toll-like receptor pathway.
2018,
Pubmed
Rabelo-Santos,
Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer.
2018,
Pubmed
Ran,
Genome engineering using the CRISPR-Cas9 system.
2013,
Pubmed
Sakuma,
Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system.
2014,
Pubmed
Santaolalla,
TLR4 activates the β-catenin pathway to cause intestinal neoplasia.
2013,
Pubmed
Schiffman,
Carcinogenic human papillomavirus infection.
2016,
Pubmed
Schlecht,
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
2001,
Pubmed
Sethman,
The innate immunity adaptor SARM translocates to the nucleus to stabilize lamins and prevent DNA fragmentation in response to pro-apoptotic signaling.
2013,
Pubmed
Summers,
Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.
2014,
Pubmed
Termini,
SOD2 immunoexpression predicts lymph node metastasis in penile cancer.
2015,
Pubmed
Termini,
Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment.
2008,
Pubmed
Wang,
Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
2013,
Pubmed
Wang,
Expression and functional analysis of Toll-like receptor 4 in human cervical carcinoma.
2014,
Pubmed
Wentzensen,
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
2015,
Pubmed
Wu,
Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines.
2013,
Pubmed
Wu,
Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway.
2016,
Pubmed
Yan,
lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p.
2020,
Pubmed
Zhang,
The expression of Foxp3 and TLR4 in cervical cancer: association with immune escape and clinical pathology.
2017,
Pubmed
Zhang,
Sirt1 Protects Endothelial Cells against LPS-Induced Barrier Dysfunction.
2017,
Pubmed
Zhao,
Toll-like receptors and prostate cancer.
2014,
Pubmed
von Knebel Doeberitz,
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
2002,
Pubmed
